These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9863281)

  • 1. Combination therapy with low-dose etretinate and eicosapentaenoic acid for psoriasis vulgaris.
    Danno K; Sugie N
    J Dermatol; 1998 Nov; 25(11):703-5. PubMed ID: 9863281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical calcipotriene ointment and etretinate: another combination therapy for psoriasis vulgaris.
    Vázquez-López F; Pérez-Oliva N; Hernandez-Mejia R
    J Am Acad Dermatol; 1997 May; 36(5 Pt 1):803. PubMed ID: 9146555
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trial of the efficacy and safety of oral etretinate with calcipotriol cream compared with etretinate alone in moderate-severe psoriasis.
    Giannetti A; Coppini M; Bertazzoni MG; Califano A; Altieri E; Pazzaglia A; Lega M; Lombardo M; Pelfini C; Veller Fornasa C; Rabbiosi G; Cespa M
    J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):91-5. PubMed ID: 10568486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporomandibular arthritis in a patient with psoriasis vulgaris under systemic etretinate therapy.
    Yamamoto T; Watanabe K; Nishioka K
    Dermatology; 2004; 209(1):77. PubMed ID: 15237278
    [No Abstract]   [Full Text] [Related]  

  • 5. Psoriasis verrucosa.
    Wakamatsu K; Naniwa K; Hagiya Y; Ichimiya M; Muto M
    J Dermatol; 2010 Dec; 37(12):1060-2. PubMed ID: 21083712
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use.
    Magis NL; Blummel JJ; Kerkhof PC; Gerritsen RM
    Eur J Dermatol; 2000; 10(7):517-21. PubMed ID: 11056421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manifest hair repigmentation associated with etretinate therapy.
    Nagase K; Inoue T; Narisawa Y
    J Dermatol; 2017 Mar; 44(3):e34-e35. PubMed ID: 27401844
    [No Abstract]   [Full Text] [Related]  

  • 8. Psoriasis verrucosa in an obese Japanese man; a prompt clinical response observed with oral etretinate.
    Okuyama R; Tagami H
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1359-61. PubMed ID: 17062076
    [No Abstract]   [Full Text] [Related]  

  • 9. Methotrexate and etretinate as concurrent therapies in severe psoriasis.
    Vanderveen EE; Ellis CN; Campbell JP; Case PC; Voorhees JJ
    Arch Dermatol; 1982 Sep; 118(9):660-2. PubMed ID: 7114868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethylpsoralen bath plus ultraviolet A combined with oral retinoid (etretinate) in the treatment of severe psoriasis.
    Väätäinen N; Hollmen A; Fräki JE
    J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):52-5. PubMed ID: 3980803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of low-dose systemic etretinate and topical calcipotriol/betamethasone dipropionate treatment for hyperkeratosis and itching in Olmsted syndrome associated with a TRPV3 mutation.
    Takeichi T; Tsukamoto K; Okuno Y; Kojima D; Kono M; Suga Y; Akiyama M
    J Dermatol Sci; 2017 Oct; 88(1):144-146. PubMed ID: 28587736
    [No Abstract]   [Full Text] [Related]  

  • 13. Response of PUVA-induced keratoses to etretinate.
    Hudson-Peacock MJ; Angus B; Farr PM
    J Am Acad Dermatol; 1996 Jul; 35(1):120-3. PubMed ID: 8682951
    [No Abstract]   [Full Text] [Related]  

  • 14. Infantile generalized pustular psoriasis: successful disease control with intermittent etretinate.
    Namba C; Murakami M; Hanakawa Y; Tohyama M; Shirakata Y; Tauchi H; Sayama K
    J Dermatol; 2014 May; 41(5):403-6. PubMed ID: 24801915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature.
    Halverstam CP; Zeichner J; Lebwohl M
    J Cutan Med Surg; 2006; 10(6):291-9. PubMed ID: 17241599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Punctate palmoplantar keratoderma with pigmentary lesions on the dorsa of feet and ankles: successful treatment with a combination of low-dose oral etretinate and topical calcipotriol.
    Horikoshi M; Kuroda K; Tajima S
    J Dermatol; 2004 Jun; 31(6):469-72. PubMed ID: 15235186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination-therapy cyclosporin-A--etretinate for psoriasis.
    Korstanje MJ; van de Staak WJ
    Clin Exp Dermatol; 1990 May; 15(3):172-3. PubMed ID: 2364569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients.
    Mahrle G; Meyer-Hamme S; Ippen H
    Arch Dermatol; 1982 Feb; 118(2):97-100. PubMed ID: 7059226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three-year follow-up study of psoriasis patients treated with low dosages of etretinate orally and corticosteroids topically.
    Polano MK; van der Rhee HJ; van der Schroeff JG
    Acta Derm Venereol; 1982; 62(4):361-4. PubMed ID: 6183880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
    Katz HI
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.